• SOC-1: Overall Survival Final Results with Drs. Rongyu Zang and Yulian Chen

  • Oct 28 2024
  • Length: 32 mins
  • Podcast

SOC-1: Overall Survival Final Results with Drs. Rongyu Zang and Yulian Chen

Listen for free

View show details

  • Summary

  • In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Rongyu Zang and Yulian Chen to discuss the SOC-1 trial. Dr. Rongyu Zang is the Director of the Department of Gynecologic Oncology, Fudan University Zhongshan Hospital, & Institute for Ovarian Cancer, Fudan University and is the Principal investigator of the SOC-1 and SUNNY trials. Dr. Yulian Chen is an Attending Physician at the Department of Gynecologic Oncology, Fudan University Zhongshan Hospital.

    Highlights:

    • The SOC-1 trial concluded that in patients with platinum-sensitive, relapsed ovarian cancer, surgery did not increase overall survival in the intention-to-treat population, but resulted in a prolongation of survival after adjustment of crossover.
    • Surgery may provide an obviously higher proportion of long-term relapse-free survivors than chemotherapy alone.
    • An active preoperative evaluation for all patients with platinum-sensitive first relapsed ovarian cancer is suggested in specialized centers.
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about SOC-1: Overall Survival Final Results with Drs. Rongyu Zang and Yulian Chen

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available